Literature DB >> 18222041

Hippocampal interneurons co-express transcripts encoding the alpha7 nicotinic receptor subunit and the cannabinoid receptor 1.

M Morales1, K Hein, Z Vogel.   

Abstract

The notion of functional interactions between the alpha7 nicotinic acetylcholine (alpha7 nACh) and the cannabinoid systems is emerging from recent in vitro and in vivo studies. Both the alpha7 nACh receptor and the cannabinoid receptor 1 (CB1) are highly expressed in the hippocampus. To begin addressing possible anatomical interactions between the alpha7 nACh and the cannabinoid systems in the rat hippocampus, we investigated the distribution of neurons expressing alpha7 nACh mRNA in relation to those containing CB1 mRNA. By in situ hybridization we found that the alpha7 nACh mRNA is diffusely expressed in principal neurons and is highly expressed in a subset of interneurons. We observed that the pattern of distribution of hippocampal interneurons co-expressing transcripts encoding alpha7 nACh and glutamate decarboxylase (GAD; synthesizing enzyme of GABA) closely resembles the one displayed by interneurons expressing CB1 mRNA. By double in situ hybridization we established that the majority of hippocampal interneurons expressing alpha7 nACh mRNA have high levels of CB1 mRNA. As CB1 interneurons contain cholecystokinin (CCK), we investigated the degree of cellular co-expression of alpha7 nACh mRNA and CCK, and found that the cellular co-existence of alpha7 nACh and CCK varies within the different layers of the hippocampus. In summary, we established that most of the hippocampal alpha7 nACh expressing interneurons are endowed with CB1 mRNA. We found that these alpha7 nACh/CB1 interneurons are the major subpopulation of hippocampal interneurons expressing CB1 mRNA. The alpha7 nACh expressing interneurons represent half of the detected population of CCK containing neurons in the hippocampus. Since it is well established that the vast majority of hippocampal interneurons expressing CB1 mRNA have 5-HT type 3 (5-HT3) receptors, we conclude that these hippocampal alpha7 nACh/5HT3/CB1/CCK interneurons correspond to those previously postulated to relay inputs from diverse cortical and subcortical regions about emotional, motivational, and physiological states.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222041      PMCID: PMC2574619          DOI: 10.1016/j.neuroscience.2007.12.019

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  55 in total

1.  Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons.

Authors:  Leonard Khiroug; Rashid Giniatullin; Rebecca C Klein; Dmitriy Fayuk; Jerrel L Yakel
Journal:  J Neurosci       Date:  2003-10-08       Impact factor: 6.167

Review 2.  Interneuron Diversity series: Rhythm and mood in perisomatic inhibition.

Authors:  Tamás F Freund
Journal:  Trends Neurosci       Date:  2003-09       Impact factor: 13.837

3.  The electron microscopic autoradiographic localization of alpha-bungarotoxin binding sites within the central nervous system of the rat.

Authors:  S P Hunt; J Schmidt
Journal:  Brain Res       Date:  1978-02-17       Impact factor: 3.252

4.  Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation.

Authors:  K Tsou; K Mackie; M C Sañudo-Peña; J M Walker
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Cholecystokinin-immunoreactive cells form symmetrical synaptic contacts with pyramidal and nonpyramidal neurons in the hippocampus.

Authors:  M G Nunzi; A Gorio; F Milan; T F Freund; P Somogyi; A D Smith
Journal:  J Comp Neurol       Date:  1985-07-22       Impact factor: 3.215

6.  Differential effects of endogenous and synthetic cannabinoids on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes.

Authors:  Murat Oz; Li Zhang; Arippa Ravindran; Marisela Morales; Carl R Lupica
Journal:  J Pharmacol Exp Ther       Date:  2004-04-21       Impact factor: 4.030

7.  The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes.

Authors:  Murat Oz; Arippa Ravindran; Oscar Diaz-Ruiz; Li Zhang; Marisela Morales
Journal:  J Pharmacol Exp Ther       Date:  2003-05-23       Impact factor: 4.030

8.  Coexistence of serotonin 3 (5-HT3) and CB1 cannabinoid receptors in interneurons of hippocampus and dentate gyrus.

Authors:  Marisela Morales; Cristina Bäckman
Journal:  Hippocampus       Date:  2002       Impact factor: 3.899

9.  Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system.

Authors:  Marisela Morales; Shwun-De Wang
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

10.  Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5-HT3A) are co-expressed in GABA neurons in the rat telencephalon.

Authors:  Marisela Morales; Shwun-De Wang; Oscar Diaz-Ruiz; Diana Hyun-Jin Jho
Journal:  J Comp Neurol       Date:  2004-01-06       Impact factor: 3.215

View more
  15 in total

Review 1.  An update on cholinergic regulation of cholecystokinin-expressing basket cells.

Authors:  Christian A Cea-del Rio; Chris J McBain; Kenneth A Pelkey
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

2.  Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca²⁺ channels and Ca²⁺ release from stores.

Authors:  Ai-Hui Tang; Miranda A Karson; Daniel A Nagode; J Michael McIntosh; Victor N Uebele; John J Renger; Matthias Klugmann; Teresa A Milner; Bradley E Alger
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

Review 3.  The interesting interplay between interneurons and adult hippocampal neurogenesis.

Authors:  Irene Masiulis; Sanghee Yun; Amelia J Eisch
Journal:  Mol Neurobiol       Date:  2011-09-29       Impact factor: 5.590

4.  Interaction of maternal choline levels and prenatal Marijuana's effects on the offspring.

Authors:  M Camille Hoffman; Sharon K Hunter; Angelo D'Alessandro; Kathleen Noonan; Anna Wyrwa; Robert Freedman
Journal:  Psychol Med       Date:  2019-07-31       Impact factor: 7.723

5.  First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors.

Authors:  Steffen B Schulz; Karin E Heidmann; Arpad Mike; Zin-Juan Klaft; Uwe Heinemann; Zoltan Gerevich
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 6.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

7.  M3 muscarinic acetylcholine receptor expression confers differential cholinergic modulation to neurochemically distinct hippocampal basket cell subtypes.

Authors:  Christian A Cea-del Rio; J Josh Lawrence; Ludovic Tricoire; Ferenc Erdelyi; Gabor Szabo; Chris J McBain
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

Review 8.  Basket cell dichotomy in microcircuit function.

Authors:  Caren Armstrong; Ivan Soltesz
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

9.  Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis.

Authors:  Walter Francesconi; Fulvia Berton; Vez Repunte-Canonigo; Kazuki Hagihara; David Thurbon; Dusan Lekic; Sheila E Specio; Thomas N Greenwell; Scott A Chen; Kenner C Rice; Heather N Richardson; Laura E O'Dell; Eric P Zorrilla; Marisela Morales; George F Koob; Pietro Paolo Sanna
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167

Review 10.  The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.

Authors:  Maria Scherma; Paola Fadda; Bernard Le Foll; Benoit Forget; Walter Fratta; Steven R Goldberg; Gianluigi Tanda
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.